Natixis Advisors, L.P. Becton Dickinson & CO Transaction History
Natixis Advisors, L.P.
- $54.1 Billion
- Q1 2025
A detailed history of Natixis Advisors, L.P. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Natixis Advisors, L.P. holds 436,600 shares of BDX stock, worth $75.4 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
436,600
Previous 205,198
112.77%
Holding current value
$75.4 Million
Previous $46.6 Million
114.82%
% of portfolio
0.18%
Previous 0.09%
Shares
31 transactions
Others Institutions Holding BDX
# of Institutions
1,806Shares Held
257MCall Options Held
3.24MPut Options Held
841K-
Vanguard Group Inc Valley Forge, PA28MShares$4.83 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY22.3MShares$3.84 Billion0.12% of portfolio
-
State Street Corp Boston, MA14MShares$2.41 Billion0.14% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD12.6MShares$2.17 Billion1.91% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.3MShares$1.95 Billion0.32% of portfolio
About BECTON DICKINSON & CO
- Ticker BDX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 285,195,008
- Market Cap $49.2B
- Description
- Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...